HPVC2016-108: Biopharmaceutical - Infliximab
Expired Contract
Contract start date: 01 Feb 2016
Contract end date: 30 Apr 2024
Option periods: Nil
Description
For the provision of Biopharmaceutical InfliximabAdditional information
Contract Details
The Principal Period commenced on 1st of February 2016 and ran until 30th of April 2018.
The first Contract Option period of two years was executed – effective from 1 May 2018 until 30 April 2020.
The second Contract Option of two years has been executed – effective from 1 May 2020 until 30 April 2022.
Contract has been extended - effective 1 May 2022 until 30 April 2024.
Option Periods Remaining
Nil
Sales Report Template
https://www.hpv.org.au/documents/details/164
(You must be a registered supplier on the HPV website and have logged in to access the link above for the new reporting template.)